Skip to main content
PolicySpeak
← The ranking

Side by side

Compare organizations

Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

BAX
Baxter

Company · United States

2
files engaged
of 583 tracked
2
positions filed
in those 583 files
0.2
declared FTE
self-declared
0
EP accreditations
as declared to the register

Declared costs: €100K+ a year · in the register since 2011

77
files engaged
of 583 tracked
87
positions filed
in those 583 files
15
declared FTE
self-declared
0
EP accreditations
as declared to the register

Declared costs: €2.8M+ a year · in the register since 2010

Files both filed on (2)

Medicinal products for human use · Fluorinated gases regulation

Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.

What each said, in their own words

Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.

Medicinal products for human use

Baxter · filed 27 Apr 2021 · source

Baxter is a global healthcare company with a leading portfolio of critical care, nutrition, renal, hospital and surgical products and we are driven by our mission to save and sustain lives. We stand ready to partner with EU policy-makers during the on-going process to modernise the EU’s regulatory environment for pharmaceuticals.

Wirtschaftskammer Österreich · filed 8 Nov 2023 · source

The Austrian Economic Chamber welcomes in principle the European Commission’s objectives under the Pharmaceutical Strategy and sees them as an opportunity to strengthen the pharmaceutical base in Austria and Europe.

Filed in German · English published by the European Commission

Fluorinated gases regulation

Wirtschaftskammer Österreich · filed 3 Sept 2020 · source

As early as 2017, it became clear that the availability of the main F-gases in the internal market will be limited. Prices were exploded and supply could no longer be guaranteed for many applications. Only between March and October 2017 did the prices of common refrigerants in Central Europe increase by ~750 %. This trend continued until 2018 and then stabilised.

Filed in German · English published by the European Commission

Baxter · filed 28 Jun 2022 · source

Baxter is a leading global pharmaceutical & medical device company committed to delivering life-saving and sustaining products. We have been working with clinicians and hospitals across Europe for years to provide anaesthetic agents (inhaled & intravenous) that allow clinical treatment to be tailored to specific patient needs.

Take this comparison with you

2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.